SCYX SCYNEXIS, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 10, 2026
$5,12
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,5752-Wochen-Tief
$6,1552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$51M
P/E (TTM)
17.7
EPS (TTM)
$0.29
Umsatz (TTM)
$19M
Ihre Abzeichen
52W-Spanne
$1–$6
Analystenbewertung
BUY
Kursziel
$36
P/E
17.7
ROE
-18.4%
Nettogewinnmarge
-53.3%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SCYX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.12
Marktkapitalisierung (MRQ)
$51M
P/E (TTM)
17.7
EPS (TTM)
$0.29
Umsatz (TTM)
$19M
ROE (TTM)
-18.4%
52W-Spanne
$1–$6
SCYX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 1. Juni 2026 | 1-for-8 | Umgekehrt |
| 17. Juli 2020 | 1-for-10 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$21M2016-12-31 → 2025-12-31
EPS$-0.172016-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2020-12-31
Nettogewinnmarge-53.3%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SCYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 17.75-Jahres-Durchschnitt ≈-2.2 | ≈-2.2 | · | · | |
| P/S (TTM) | 2.75-Jahres-Durchschnitt ≈6.1 | ≈6.1 | 34.3 | Unterbewertet | |
| K/B (MRQ) | 0.85-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 1.7 | Unterbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | -9.65-Jahres-Durchschnitt ≈-1.6 | ≈-1.6 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.05-Jahres-Durchschnitt ≈5.0 | ≈5.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SCYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -117.7%5-Jahres-Durchschnitt ≈-675.4% | ≈-675.4% | -3308.5% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | -78.0%5-Jahres-Durchschnitt ≈-675.4% | ≈-675.4% | -1707.4% | Unterdurchschnittlich | |
| Pretax Margin (Vorgewinnmarge) | -41.8%5-Jahres-Durchschnitt ≈-471.0% | ≈-471.0% | -113.6% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -53.3%5-Jahres-Durchschnitt ≈-449.0% | ≈-449.0% | -41.3% | Spitzenklasse | |
| ROA (TTM) | -15.1%5-Jahres-Durchschnitt ≈-7.4% | ≈-7.4% | -59.6% | Spitzenklasse | |
| ROE (TTM) | -18.4%5-Jahres-Durchschnitt ≈-147.3% | ≈-147.3% | -112.1% | Spitzenklasse | |
| ROIC | -32.6%5-Jahres-Durchschnitt ≈-617.2% | ≈-617.2% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SCYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 9.75-Jahres-Durchschnitt ≈5.2 | ≈5.2 | 3.3 | Starke Liquidität | |
| Quick Ratio | 7.05-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 3.1 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | SCYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 450.0%5-Jahres-Durchschnitt ≈736.0% | ≈736.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 59.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | SCYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.35-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.0 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.1M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
26.4%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 17, 2026 | $0.63 | $-0.52 | 221.9% |
| 31. März 2026 | Mai 13, 2026 | $-3.36 | $-1.01 | -233.9% |
| 31. Dezember 2025 | $1.94 | $1.03 | 87.3% | |
| 30. September 2025 | $-1.36 | $-1.63 | 16.7% | |
| 30. Juni 2025 | $-1.12 | $-1.55 | 27.8% | |
| 31. März 2025 | $-0.11 | $-0.18 | 38.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21M | $4M | $140M | $5M | $13M | $0 | $121.0K | $257.0K | $257.0K | $257.0K | $257.0K | $1M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $15M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| R&D Expense | $22M | $26M | $31M | $27M | $24M | $37M | $38M | $22M | $18M | $20M | $16M | $8M | |
| SG&A Expense | $14M | $14M | $21M | $63M | $50M | $15M | $11M | $9M | $8M | $8M | $12M | $8M | |
| Operating Expenses | $37M | $41M | $67M | $91M | $74M | $51M | $49M | $30M | $27M | $28M | $29M | $16M | |
| Operating Income | $-16M | $-37M | $73M | $-86M | $-61M | $-51M | $-49M | $-30M | $-26M | $-28M | $-28M | $-15M | |
| Interest Expense | · | · | $3M | $5M | $3M | $1M | $986.0K | $2M | $1M | $351.0K | $-11.0K | $48.0K | |
| Other Non-op | $7M | $16M | $-5M | $18M | $25M | $-7M | $-5M | $11M | $1M | $-2M | $0 | $-10.0K | |
| Pretax Income | $-9M | $-21M | $67M | $-68M | $-36M | $-58M | $-54M | $-19M | $-25M | $-30M | $-28M | $-7M | |
| Income Tax | $0 | $151.0K | $138.0K | $-5M | $-3M | $-3M | $0 | $-7M | $0 | $0 | $0 | $-1M | |
| Net Income | $-9M | $-21M | $67M | $-63M | $-33M | $-55M | $-54M | $-12M | $-25M | $-30M | $-33M | $-4M | |
| EPS (Basic) | $-0.17 | $-0.44 | $1.40 | $-1.47 | $-1.25 | · | · | · | · | $-1.58 | $-2.68 | $-1.04 | |
| EPS (Diluted) | $-0.17 | $-0.44 | $1.39 | $-1.47 | $-1.25 | · | · | · | · | $-1.58 | $-2.68 | $-2.69 | |
| Shares (Basic) | 49,933,381 | 48,513,073 | 47,852,833 | 42,613,510 | 26,384,713 | · | · | · | · | 19,035,299 | 12,163,559 | 5,663,311 | |
| Shares (Diluted) | 49,933,381 | 48,513,073 | 48,390,582 | 42,613,510 | 26,384,713 | · | · | · | · | 19,035,299 | 12,163,559 | 5,937,087 | |
| EBITDA | $-16M | $-37M | $73M | $-86M | · | $-51M | · | $-30M | $-26M | $-28M | $-28M | $-12M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $16M | $34M | $46M | $104M | $93M | $42M | $11M | $11M | $36M | $47M | $32M | |
| Short-term Investments | $19M | $43M | $40M | $28M | $0 | · | · | · | · | $23M | $0 | · | |
| Receivables | · | · | $0 | $2M | $861.0K | $0 | · | · | · | · | · | $1M | |
| Inventory | · | · | $0 | $899.0K | $463.0K | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $263.0K | $2M | $6M | $3M | $4M | $5M | $4M | $7M | $1M | $741.0K | $1M | $703.0K | |
| Other Current Assets | $17.0K | $1M | $5M | $62.0K | $4.0K | $373.0K | $674.0K | $54.0K | $91.0K | $41.0K | $38.0K | $3.0K | |
| Current Assets | $40M | $72M | $102M | $79M | $109M | $98M | $52M | $51M | $45M | $59M | $48M | $40M | |
| PP&E (Net) | · | · | · | · | $113.0K | $298.0K | $405.0K | $516.0K | $4.0K | · | $42.0K | $0 | |
| PP&E (Gross) | · | · | · | · | $580.0K | $580.0K | $577.0K | $577.0K | $12.0K | · | $42.0K | $22M | |
| Accum. Depreciation | · | · | · | · | $467.0K | $282.0K | $172.0K | $61.0K | $8.0K | · | $0 | $17M | |
| Intangibles | · | · | $0 | $408.0K | $1M | $0 | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | $0 | $6M | $6M | $573.0K | $812.0K | $812.0K | $572.0K | $120.0K | $419.0K | $25.0K | |
| Total Assets | $59M | $91M | $128M | $88M | $120M | $103M | $57M | $53M | $46M | $60M | $49M | $40M | |
| Accounts Payable | $2M | $5M | $7M | $6M | $8M | $5M | $7M | $4M | $4M | $2M | $619.0K | $426.0K | |
| Accrued Liabilities | $3M | $4M | $7M | $6M | $6M | $4M | $4M | $2M | $2M | $1M | $3M | $2M | |
| Current Liabilities | $6M | $24M | $16M | $18M | $14M | $26M | $11M | $6M | $10M | $4M | $7M | $5M | |
| Capital Leases | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $3M | $0 | · | · | · | · | · | · | |
| Total Liabilities | $10M | $36M | $55M | $85M | $79M | $80M | $44M | $22M | $24M | $25M | $7M | $6M | |
| Long-term Debt | · | · | · | · | $34M | · | · | $15M | $15M | $14M | · | · | |
| Total Debt | · | · | · | · | · | · | · | $15M | $15M | $14M | · | $0 | |
| Paid-in Capital | $435M | $432M | $428M | $425M | $401M | $349M | $284M | $249M | $227M | $215M | $192M | $151M | |
| Retained Earnings | $-385M | $-377M | $-355M | $-422M | $-359M | $-327M | $-271M | $-218M | $-205M | $-180M | $-150M | $-118M | |
| Stockholders' Equity | $49M | $55M | $73M | $3M | $41M | $23M | $13M | $31M | $21M | $35M | $42M | $33M | |
| Liabilities + Equity | $59M | $91M | $128M | $88M | $120M | $103M | $57M | $53M | $46M | $60M | $49M | $40M | |
| Shares Outstanding | 5,442,688 | 4,746,748 | 37,207,799 | 32,682,342 | 28,705,334 | 19,663,698 | 9,741,372 | 4,797,198 | 28,971,651 | 24,609,411 | 13,905,599 | 8,512,103 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $0 | $580.0K | $606.0K | $379.0K | $111.0K | · | · | · | · | · | · | |
| Stock-based Comp | $3M | $3M | $3M | $4M | $2M | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $400.0K | $700.0K | $200.0K | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-5M | $-24M | $60M | $-80M | $-55M | $-49M | $-38M | $-28M | $-25M | $-29M | $-25M | $-9M | |
| CapEx | · | · | · | · | $0 | $4.0K | $0 | $565.0K | $2.0K | $27.0K | $589.0K | $704.0K | |
| Investing Cash Flow | $24M | $6M | $-35M | $-27M | $-1M | $6M | $26M | $-803.0K | $-10M | $-22M | $2M | $-488.0K | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $0 | $0 | · | |
| Stock Issued | $5.0K | $0 | $0 | $47M | $39M | $91M | $46M | $32M | $10M | $28M | $41M | $62M | |
| Net Stock Activity | $5.0K | · | $0 | $47M | · | $91M | · | $32M | $10M | $28M | $41M | $62M | |
| Financing Cash Flow | $-14M | $-139.0K | $-37M | $49M | $67M | $94M | $42M | $29M | $10M | $40M | $38M | $41M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-24M | $-11M | $15M | $31M | |
| Free Cash Flow | · | · | · | · | · | $-49M | · | $-29M | $-25M | $-29M | $-25M | $-10M | |
| Levered FCF | · | · | · | · | · | $-50M | · | $-30M | $-26M | $-30M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 18.8% | |
| Operating Margin | -78.0% | -990.8% | 51.8% | -1684.5% | · | · | · | -11666.5% | -10241.2% | -10823.7% | -11030.7% | -63.7% | |
| Net Margin | -41.8% | -568.3% | 47.8% | -1233.7% | · | · | · | -4851.4% | -9751.0% | -11668.9% | -12693.8% | -22.3% | |
| Pretax Margin | -41.8% | -564.3% | 47.9% | -1326.0% | · | · | · | -7472.4% | -9766.5% | -11668.9% | -11026.5% | · | |
| EBITDA Margin | -78.0% | -990.8% | 51.8% | -1684.5% | · | · | · | -11666.5% | -10241.2% | -10823.7% | -11030.7% | -63.7% | |
| ROA | -11.5% | -19.4% | 62.0% | -60.5% | · | -69.1% | · | -25.2% | -47.4% | -55.0% | -73.4% | -16.3% | |
| ROE | -18.4% | -37.5% | 81.3% | -614.5% | · | -341.5% | · | -42.2% | -103.0% | -78.1% | -86.6% | 11.3% | |
| ROIC | -32.6% | -67.9% | 99.4% | -2467.9% | · | -212.6% | · | -42.0% | -73.0% | -56.7% | -67.6% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 3.0 | 6.3 | 4.5 | · | 3.7 | · | 8.8 | 4.4 | 16.0 | 7.3 | 9.1 | |
| Quick Ratio | 7.0 | 2.5 | 4.6 | 4.3 | · | 3.5 | · | 1.9 | 1.1 | 15.8 | 7.1 | 8.8 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.7 | 0.4 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.5 | 0.4 | · | · | |
| Interest Coverage | · | · | 23.2 | -16.5 | · | -43.3 | · | -18.4 | -18.1 | -79.3 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.0 | 1.3 | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | |
| Receivables Turnover | · | · | 133.4 | 3.4 | · | · | · | · | · | · | · | 20.7 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.13 | $1.45 | $1.96 | $0.10 | · | $1.16 | · | $0.65 | $0.74 | $1.41 | $3.02 | $3.93 | |
| Revenue / Share | $0.41 | $0.08 | $2.90 | $0.12 | · | · | · | · | · | $0.01 | $0.02 | $3.20 | |
| Cash Flow / Share | $-0.11 | $-0.49 | $1.24 | $-1.87 | · | · | · | · | · | $-1.54 | $-2.02 | $-1.60 | |
| Cash / Share | $0.49 | $0.42 | $0.92 | $1.40 | · | $4.73 | · | $0.24 | $0.40 | $1.45 | $3.38 | $3.79 | |
| EPS (TTM) | $-0.17 | $-0.44 | $1.39 | $-1.47 | $-1.25 | $-3.09 | · | · | · | $-1.58 | $-2.68 | $-2.69 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 450.0% | -97.3% | 2652.7% | -61.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 59.4% | -34.2% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $21M | $4M | $140M | $5M | $13M | $0 | $121.0K | $257.0K | $257.0K | $257.0K | $257.0K | $1M | |
| Net Income TTM | $-9M | $-21M | $67M | $-63M | $-33M | $-55M | $-54M | $-12M | $-25M | $-30M | $-33M | $-4M | |
| Market Cap | $28M | $46M | $83M | $51M | · | $150M | · | $231M | $672M | $785M | $864M | $850M | |
| Enterprise Value | · | · | · | · | · | · | · | $235M | $675M | $741M | · | $817M | |
| P/E | -3.7 | -2.8 | 1.6 | -1.1 | -4.9 | -2.5 | · | · | · | -20.2 | -23.2 | -37.1 | |
| P/S | 1.3 | 12.3 | 0.6 | 10.0 | · | · | · | 899.7 | 2615.3 | 3054.6 | 3360.1 | 676.4 | |
| P/B | 0.6 | 0.8 | 1.1 | 15.8 | · | 6.6 | · | 7.4 | 31.4 | 22.5 | 20.6 | 25.4 | |
| P / Tangible Book | 0.6 | 0.8 | 1.1 | 18.0 | 4.4 | 6.6 | · | · | · | · | · | · | |
| P / Cash Flow | -5.2 | -1.9 | 1.4 | -0.6 | · | -3.0 | · | -8.2 | -27.4 | -26.7 | -35.2 | -89.7 | |
| P / FCF | · | · | · | · | · | -3.0 | · | -8.0 | -27.4 | -26.7 | -34.4 | -83.5 | |
| EV / EBITDA | · | · | · | · | · | · | · | -7.8 | -25.7 | -26.6 | · | -67.5 | |
| EV / FCF | · | · | · | · | · | · | · | -8.1 | -27.5 | -25.2 | · | -80.3 | |
| EV / Revenue | · | · | · | · | · | · | · | 913.9 | 2627.7 | 2882.1 | · | 650.7 | |
| Earnings Yield | -26.9% | -36.4% | 62.3% | -94.2% | -20.5% | -40.4% | · | · | · | -5.0% | -4.3% | -2.7% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $235.0K | $0 | $19M | $334.0K | $1M | $257.0K | $977.0K | $660.0K | $736.0K | $1M | $6M | $2M | $131M | $1M | $2M | $2M | |
| R&D Expense | $4M | $12M | $5M | $5M | $7M | $5M | $4M | $8M | $7M | $7M | $11M | $6M | $7M | $7M | $8M | $6M | |
| SG&A Expense | $4M | $5M | $4M | $3M | $4M | $4M | $5M | $3M | $3M | $4M | $4M | $5M | $7M | $5M | $16M | $17M | |
| Operating Expenses | $8M | $17M | $8M | $9M | $11M | $9M | $9M | $11M | $10M | $11M | $29M | $12M | $15M | $12M | $24M | $23M | |
| Operating Income | $-8M | $-17M | $11M | $-8M | $-10M | $-9M | $-8M | $-10M | $-9M | $-10M | $-23M | $-10M | $117M | $-11M | $-22M | $-22M | |
| Interest Expense | · | · | · | · | · | · | · | · | $197.0K | $205.0K | · | $212.0K | $1M | $1M | $2M | $1M | |
| Other Non-op | $15M | $-4M | $2M | $-186.0K | $3M | $3M | $4M | $7M | $-5M | $10M | $4M | $8M | $6M | $-23M | $8M | $-8M | |
| Pretax Income | · | · | $12M | $-9M | $-7M | $-5M | $-4M | $-3M | $-14M | $942.0K | $-19M | $-2M | $122M | $-34M | $-14M | $-30M | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | $15.0K | $-395.0K | $0 | $531.0K | $138.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $7M | $-21M | $12M | $-9M | $-7M | $-5M | $-4M | $-3M | $-14M | $411.0K | $-20M | $-2M | $122M | $-34M | $-14M | $-30M | |
| EPS (Basic) | $0.63 | $-0.42 | $0.25 | $-0.17 | $-1.11 | $-0.11 | $-0.09 | $-0.06 | $-0.30 | $0.01 | $-0.41 | $-0.04 | $2.56 | $-0.71 | $-0.37 | $-0.62 | |
| EPS (Diluted) | $0.63 | $-0.42 | $0.25 | $-0.17 | $-1.11 | $-0.11 | $-0.09 | $-0.06 | $-0.30 | $0.01 | $-0.32 | $-0.04 | $2.46 | $-0.71 | $-0.36 | $-0.62 | |
| Shares (Basic) | 11,824,078 | 50,957,191 | · | 49,898,892 | 6,218,614 | 49,435,500 | · | 48,618,693 | 48,511,656 | 48,245,559 | · | 47,891,996 | 47,837,393 | 47,757,246 | · | 47,503,821 | |
| Shares (Diluted) | 11,824,078 | 50,957,191 | · | 49,898,892 | 6,218,614 | 49,435,500 | · | 48,618,693 | 48,511,656 | 48,565,051 | · | 47,891,996 | 49,923,361 | 47,757,246 | · | 47,503,821 | |
| EBITDA | $-8M | $-17M | · | $-8M | $-10M | $-9M | · | $-10M | $-9M | $-10M | · | $-10M | $117M | $-11M | · | $-22M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $37M | $21M | $15M | $11M | $7M | $16M | $29M | $26M | $35M | $34M | $44M | $58M | $27M | $46M | $69M | |
| Short-term Investments | $44M | $23M | $19M | $23M | $34M | $34M | $43M | $40M | $47M | $45M | $40M | $44M | $28M | $28M | $28M | $27M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $2M | $2M | $2M | $2M | $2M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $13M | $10M | $1M | $899.0K | $786.0K | |
| Prepaid Expense | $2M | $919.0K | $263.0K | $686.0K | $2M | $1M | $2M | $2M | $1M | $2M | $6M | $3M | $3M | $2M | $3M | $4M | |
| Other Current Assets | $930.0K | $569.0K | $17.0K | $195.0K | $867.0K | $891.0K | $1M | $953.0K | $554.0K | $556.0K | $5M | $2M | $1M | $291.0K | $62.0K | $4.0K | |
| Current Assets | $56M | $63M | $40M | $49M | $56M | $52M | $72M | $80M | $95M | $102M | $102M | $129M | $146M | $60M | $79M | $104M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | $103.0K | $206.0K | $309.0K | $408.0K | $770.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $25.0K | $64.0K | $7M | $6M | $5M | |
| Total Assets | $75M | $78M | $59M | $51M | $61M | $68M | $91M | $99M | $108M | $118M | $128M | $149M | $155M | $70M | $88M | $112M | |
| Accounts Payable | $3M | $6M | $2M | $3M | $6M | $4M | $5M | $5M | $5M | $9M | $7M | $3M | $3M | $6M | $6M | $7M | |
| Accrued Liabilities | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $6M | $5M | $5M | $7M | $10M | $7M | $5M | $6M | $6M | |
| Current Liabilities | $6M | $16M | $6M | $8M | $11M | $9M | $24M | $26M | $25M | $27M | $16M | $17M | $16M | $46M | $18M | $14M | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Total Liabilities | $8M | $36M | $10M | $15M | $16M | $17M | $36M | $41M | $47M | $44M | $55M | $57M | $62M | $100M | $85M | $95M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $35M | · | $34M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Paid-in Capital | $466M | $448M | $434M | $434M | $433M | $432M | $432M | $431M | $430M | $429M | $428M | $428M | $427M | $426M | $425M | $425M | |
| Retained Earnings | $-399M | $-406M | $-385M | $-397M | $-389M | $-382M | $-377M | $-372M | $-369M | $-355M | $-355M | $-336M | $-334M | $-456M | $-422M | $-408M | |
| Stockholders' Equity | $67M | $41M | $49M | $36M | $44M | $51M | $55M | $59M | $60M | $74M | $73M | $92M | $93M | $-30M | $3M | $17M | |
| Liabilities + Equity | $75M | $78M | $59M | $51M | $61M | $68M | $91M | $99M | $108M | $118M | $128M | $149M | $155M | $70M | $88M | $112M | |
| Shares Outstanding | 9,949,609 | 62,051,330 | 43,541,510 | 41,956,724 | 39,174,941 | 39,020,274 | 37,973,991 | 37,943,241 | 37,856,463 | 37,779,796 | 37,207,799 | 37,175,815 | 37,175,665 | 33,327,627 | 32,682,342 | 32,656,242 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $0 | $129.0K | $147.0K | $153.0K | $151.0K | $155.0K | $150.0K | |
| Stock-based Comp | $568.0K | $580.0K | $687.0K | $526.0K | $820.0K | $819.0K | $981.0K | $901.0K | $759.0K | $705.0K | $557.0K | $632.0K | $728.0K | $707.0K | $454.0K | $1M | |
| Operating Cash Flow | $-15M | $-8M | $18M | $-9M | $-7M | $-7M | $-10M | $765.0K | $-11M | $-4M | $-8M | $12M | $74M | $-19M | $-23M | $-23M | |
| Investing Cash Flow | $-25M | $-525.0K | $-12M | $12M | $11M | $12M | $-3M | $2M | $1M | $5M | $-2M | $-26M | $-6M | $0 | $0 | $-27M | |
| Stock Issued | · | · | $1.0K | · | · | · | $0 | · | · | · | · | $-4.0K | $4.0K | $0 | $0 | $95.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $13M | $24M | $-115.0K | $29.0K | $0 | $-14M | $-155.0K | $31.0K | $0 | $-15.0K | $-135.0K | $34.0K | $-37M | $22.0K | $0 | $-183.0K |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3308.5% | · | · | -2516.5% | -701.0% | -3350.2% | · | -1563.6% | -1255.0% | -692.5% | · | -573.4% | 88.6% | -945.3% | · | -1400.2% | |
| Net Margin | 3147.7% | · | · | -2572.2% | -504.8% | -2097.7% | · | -425.5% | -1964.4% | 29.9% | · | -99.8% | 93.0% | -2997.9% | · | -1900.1% | |
| Pretax Margin | · | · | · | -2572.2% | -504.8% | -2097.7% | · | -485.3% | -1964.4% | 68.6% | · | -99.8% | 93.0% | -2997.9% | · | -1900.1% | |
| EBITDA Margin | -3308.5% | · | · | -2516.5% | -701.0% | -3350.2% | · | -1563.6% | -1255.0% | -692.5% | · | -573.4% | 88.6% | -945.3% | · | -1400.2% | |
| ROA | 10.9% | -29.3% | · | -11.5% | -8.2% | -5.8% | · | -2.3% | -11.0% | 0.44% | · | -1.4% | 84.2% | -37.3% | · | -26.6% | |
| ROE | 13.3% | -46.4% | · | -18.1% | -13.1% | -8.6% | · | -3.7% | -18.8% | 1.9% | · | -3.2% | 176.5% | -751.7% | · | -107.9% | |
| ROIC | · | · | · | -23.1% | -21.5% | -17.0% | · | -15.5% | -15.3% | -5.6% | · | -11.0% | 125.2% | 35.7% | · | -126.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | 3.9 | · | 5.7 | 5.2 | 5.8 | · | 3.1 | 3.7 | 3.7 | · | 7.7 | 9.0 | 1.3 | · | 7.3 | |
| Quick Ratio | 9.3 | 3.7 | · | 4.5 | 4.1 | 4.5 | · | 2.7 | 2.9 | 2.9 | · | 5.4 | 5.4 | 1.2 | · | 6.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -46.9 | -46.4 | · | -47.6 | 93.3 | -7.4 | · | -15.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.9 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.7 | 57.7 | 0.6 | · | 1.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.73 | $0.67 | · | $0.87 | $1.14 | $1.29 | · | $1.54 | $1.60 | $1.96 | · | $2.47 | $2.50 | $-0.90 | · | $0.53 | |
| Revenue / Share | $0.02 | $0.00 | · | $0.01 | $0.03 | $0.01 | · | $0.01 | $0.02 | $0.03 | · | $0.04 | $2.63 | $0.02 | · | $0.03 | |
| Cash Flow / Share | · | $-0.16 | · | · | · | $-0.15 | · | · | · | $-0.08 | · | · | · | $-0.40 | · | · | |
| Cash / Share | $1.05 | $0.59 | · | $0.35 | $0.28 | $0.18 | · | $0.76 | $0.69 | $0.94 | · | $1.19 | $1.56 | $0.81 | · | $2.10 | |
| EPS (TTM) | $0.29 | $-1.45 | · | $-1.48 | $-1.37 | $-0.56 | · | $-0.67 | $-0.65 | $2.11 | · | $1.35 | $0.77 | $-2.00 | · | $-1.85 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $20M | · | $3M | $3M | $3M | · | $9M | $10M | $140M | · | $136M | $136M | $6M | · | $4M | |
| Net Income TTM | $-10M | $-25M | · | $-25M | $-20M | $-27M | · | $-36M | $-35M | $101M | · | $72M | $44M | $-91M | · | $-78M | |
| Market Cap | $40M | $57M | · | $32M | $26M | $37M | · | $57M | $76M | $56M | · | $85M | $110M | $100M | · | $78M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-18M | |
| P/E | 14.0 | -0.6 | · | -0.5 | -0.5 | -1.7 | · | -2.2 | -3.1 | 0.7 | · | 1.7 | 3.8 | -1.5 | · | -1.3 | |
| P/S | 2.1 | 2.8 | · | 11.0 | 8.1 | 14.1 | · | 6.6 | 7.8 | 0.4 | · | 0.6 | 0.8 | 18.1 | · | 18.8 | |
| P/B | 0.6 | 1.4 | · | 0.9 | 0.6 | 0.7 | · | 1.0 | 1.3 | 0.7 | · | 0.9 | 1.2 | -3.3 | · | 4.6 | |
| P / Tangible Book | 0.6 | 1.4 | · | 0.9 | 0.6 | 0.7 | · | 1.0 | 1.3 | 0.7 | · | 0.9 | 1.2 | · | · | 4.8 | |
| P / Cash Flow | · | -7.0 | · | · | · | -5.0 | · | · | · | -13.9 | · | · | · | -5.3 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -4.3 | |
| Earnings Yield | 7.1% | -158.1% | · | -192.2% | -203.0% | -58.8% | · | -45.0% | -32.5% | 143.5% | · | 59.2% | 26.1% | -66.7% | · | -77.1% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $21M | $4M | $140M | $5M | $13M |
| Betriebsgewinnmarge % | -78.0% | -990.8% | 51.8% | -1684.5% | · |
| Nettoergebnis | $-9M | $-21M | $67M | $-63M | $-33M |
| Verwässerte EPS | $-0.17 | $-0.44 | $1.39 | $-1.47 | $-1.25 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 7.0 | 3.0 | 6.3 | 4.5 | · |
| Quick Ratio | 7.0 | 2.5 | 4.6 | 4.3 | · |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 4 Einreicher · $1.3M gesamt · Stand 31. März 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
4
Gehaltener Wert
$1.3M
Neue Positionen
16
Geschlossene Positionen
6
Institutionelle Aktivität — Q1 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 16 (+10 vs. Vorquartal) | 6 (-3 vs. Vorquartal) | 8 (-2 vs. Vorquartal) | 11 (+3 vs. Vorquartal) | +21.2M |
Verglichen mit Q4 2025. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.113.787 | 1.762.322 | 85,21% | Aktien |
| AMH Equity Ltd | $189.373 | 245.939 | 14,49% | Aktien |
| Sandy Spring Bank | $3.809 | 4.000 | 0,29% | Aktien |
| CWM, LLC | $175 | 191 | 0,01% | Aktien |
Unternehmensinsider 29 Insider · 10 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Gonzalez David Angulo | Chief Executive Officer | 1. April 2026 P | 1.357.126 | 0 | 0 | $0 |
| Marco Taglietti | Chief Executive Officer | 26. April 2022 A | 272.068 | 0 | 0 | $0 |
| Sanjay Subramanian | Chief Financial Officer | 9. September 2026 A | · | 0 | 0 | $0 |
| Ivor Macleod | Chief Financial Officer | 29. Januar 2026 A | 398.529 | 0 | 0 | $0 |
| Eric Francois | Chief Financial Officer | 29. Januar 2021 A | 11.732 | 0 | 0 | $0 |
| Jr. Charles F Osborne, | Chief Financial Officer | 1. April 2015 A | · | 0 | 0 | $0 |
| Scott Sukenick | Chief Legal Officer | 29. Januar 2026 A | 574.539 | 0 | 0 | $0 |
| Christine Coyne | Chief Commercial Officer | 4. Februar 2022 A | 58.200 | 0 | 0 | $0 |
| Carole Sable | Chief Medical Officer | 18. Juni 2014 A | · | 0 | 0 | $0 |
| Eileen Pruette | General Counsel | 18. Juni 2014 A | · | 0 | 0 | $0 |
| Steven Keith Burke | Direktor | 18. September 2026 A | 5.750 | 0 | 0 | $0 |
| Brian Philippe Tinmouth | Direktor | 26. Juni 2026 A | 12.125 | 0 | 0 | $0 |
| Guy Macdonald | Direktor | 26. Juni 2026 A | 12.625 | 0 | 0 | $0 |
| Ann Hanham | Direktor | 26. Juni 2026 A | 11.577 | 0 | 0 | $0 |
| David C Hastings | Direktor | 26. Juni 2026 A | 11.522 | 0 | 0 | $0 |
| Armando Anido | Direktor | 26. Juni 2026 A | 11.750 | 0 | 0 | $0 |
| Steven C Gilman | Direktor | 26. Juni 2025 A | 70.000 | 0 | 0 | $0 |
| Patrick Machado | Direktor | 2. Januar 2019 A | 60.000 | 0 | 0 | $0 |
| Marion Mccourt | Direktor | 2. Juli 2018 A | · | 0 | 0 | $0 |
| Patrick Langlois | Direktor | 3. Januar 2017 A | 10.503 | 0 | 0 | $0 |
| Yves J Ribeill | Direktor | 22. Juli 2015 A | 1.190 | 0 | 0 | $0 |
| Edward Penhoet | Direktor | 4. Juni 2015 A | · | 0 | 0 | $0 |
| Jean-Yves Nothias | Direktor | 1. April 2015 A | 295.077 | 0 | 0 | $0 |
| Pamela J Kirby | Direktor | 1. April 2015 A | 25.590 | 0 | 0 | $0 |
| Laurent Arthaud | Direktor | 11. Juni 2014 A | 4.507 | 0 | 0 | $0 |
| Mounia Chaoui | Direktor | 11. Juni 2014 A | · | 0 | 0 | $0 |
| Ventech Capital II | 10%-Eigentümer | 7. Mai 2014 C | 414.211 | 0 | 0 | $0 |
| F.C.P.R. Genavent | 10%-Eigentümer | 7. Mai 2014 C | 237.598 | 0 | 0 | $0 |
| FCPR Biotechnology Fund | 10%-Eigentümer | 7. Mai 2014 C | 295.077 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
SCYX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 9 Analysten
KAUF
Median-Ziel
$33.00
+544,5%
3 33,3%
Starker Kauf
5 55,6%
Kauf
1 11,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-10-03Mittelwert-Ziel $36.33 +609,6%
← Unter allen Zielen
Aktueller Preis $5.12
Tief$32.00
Mittelwert$36.33
Hoch$44.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | · |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| IMA | · | -0.7 | -77.1% | -5668.6% | 192.1% | · |
| BSEM | · | · | · | · | · | · |
| LONA | $71M | -0.3 | · | · | -353.4% | · |
| FLNA | · | · | · | · | -112.1% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026